Meanwhile, the correlation analysis and prognostic analysis in this study showed that the expression level of AKR1C2 was closely related to gender, tumor stage, and lymph node metastasis of LUAD patients and that the prognosis of patients with high AKR1C2 expression was worse. This evidence concerns the gene AKR1C2 and metastatic malignant neoplasm in the lymph nodes.